Drug Type Allergen extract |
Synonyms 300 IR grass pollen allergen extract, Five-grass pollen immunotherapy, Grass pollen allergy immunotherapy + [6] |
Target- |
Action modulators |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Germany (01 Sep 2008), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Grass pollen allergy immunotherapy(Stallergenes Greer Ltd.) | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Rhinitis, Allergic, Seasonal | Germany | - | 01 Sep 2008 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypersensitivity | Phase 3 | France | 10 May 2021 | |
Hypersensitivity | Phase 3 | Latvia | 10 May 2021 | |
Hypersensitivity | Phase 3 | Poland | 10 May 2021 | |
House dust mite allergy | Phase 3 | - | 01 Oct 2007 | |
Rhinitis, Allergic | Phase 3 | - | 01 Oct 2007 |
Phase 2/3 | 509 | nejptqxzzu(mdaeyipvgu) = idvfjgyhlw jvcuahjvnx (vxtaljtynk, 0.224) View more | - | 19 May 2016 | |||
nejptqxzzu(mdaeyipvgu) = wuvmhvqbyk jvcuahjvnx (vxtaljtynk, 0.230) View more | |||||||
Not Applicable | 581 | 300IR tablet | jteojtkxab(ujywofegjn) = nmauxbztew vssodgddtr (lelscfbiex ) | - | 01 Sep 2012 | ||
Not Applicable | 633 | 300 IR sublingual tablet of 5-grass pollen allergen extract | dltjvltoln(iwskvahckc) = pavvkxpysi ttviczapav (ubicmpabjr ) | - | 01 Feb 2012 | ||
Placebo | dltjvltoln(iwskvahckc) = vaxaqdnckz ttviczapav (ubicmpabjr ) | ||||||
Not Applicable | 89 | 300IR SLIT tablets | exodqsmtjw(dvugktjblt): difference of adjusted means = -1.97 (95% CI, -2.99 to -0.94), P-Value = 0.0003 | Positive | 14 Mar 2009 | ||
Placebo |